Expert consensus on maintenance treatment for metastatic colorectal cancer in China

Cancer Communications

Lin Shen¹  Ai-Ping Zhou¹  Jian-Ming Xu³  Tian-Shu Liu⁴  Jun Zhang⁶  Xiang-Lin Yuan⁷  Xi-Jing Wang⁸  Ying Yuan⁹  Jin Li⁹  Yu-Hong Li^1,10  Yi Ba^1,11  Xiao-Ping Qian^1,13  Yong-Qian Shu^1,14  Yan-Hong Deng^1,15  Feng Bi^1,16  Rui-Hua Xu^1,17  Gong Chen^1,17  Li Bai^1,18  Chun-Mei Bai^1,18 

[1]State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, P. R. China

[2]Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China

[3]Department of Gastrointestinal Medical Oncology, Peking University Cancer Hospital, Beijing, P. R. China

[4]Department of Gastrointestinal Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P. R. China

[5]Department of Medical Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, P. R. China

[6]Department of Medical Oncology, Fudan University Zhongshan Hospital, Shanghai, P. R. China

[7]Department of Medical Oncology, Jiangsu Provincial Hospital, Nanjing, P. R. China

[8]Department of Medical Oncology, Peking Union Medical College Hospital, Beijing, P. R. China

[9]Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China

[10]Department of Medical Oncology, The 301th Hospital of Chinese People’

[11]Department of Medical Oncology, The 307th Hospital of Chinese People’

[12]Department of Medical Oncology, The Second Hospital of Zhejiang University School of Medicine, Hangzhou, P. R. China

[13]Department of Medical Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P. R. China

[14]Department of Medical Oncology, West China Hospital of Sichuan University, Chengdu, P. R. China

[15]Department of Oncology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China

[16]Department of Oncology, Tongji University Tianyou Hospital, Shanghai, P. R. China

[17]Sun Yat-sen University Cancer Center

[18]s Liberation Army, Beijing, P. R. China

关键词: Metastatic colorectal cancer;    Maintenance therapy;    Consensus;   

DOI  :  10.1186/s40880-015-0067-x

学科分类：肿瘤学

来源: Springer

【 摘 要 】

The impact of maintenance therapy on progression-free survival and overall survival as well as quality of life of Chinese patients with metastatic colorectal cancer has long been under discussion. Recently, some phase III clinical trials have revealed that maintenance therapy can significantly prolong the progression-free survival while maintain an acceptable safety profile. Based on this evidence and common treatment practice in China, we now generated one Expert Consensus on Maintenance Treatment for Metastatic Colorectal Cancer in China to further specify the necessity of maintenance therapy, suitable candidates for such treatment, and appropriate regimens.

【 授权许可】

CC BY